share_log

UBS Initiates Coverage On Chimera Investment With Neutral Rating, Announces Price Target of $5.5

Benzinga ·  Dec 6, 2023 07:52

UBS analyst Douglas Harter initiates coverage on Chimera Investment (NYSE:CIM) with a Neutral rating and announces Price Target of $5.5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment